This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
500mg | $249 | Check With Us |
1g | $390 | Check With Us |
5g | $975 | Check With Us |
Cat #: V1965 CAS #: 187164-19-8 Purity ≥ 98%
Description: Luliconazole (also known as NND-502; NND502; Luzu) is an imidazole-based antifungal drug that is used for the topical treatment of interdigital tinea pedis. Luliconazole is a broad-spectrum antifungal agent that inhibits growth of all filamentous fungi except zygomycetes at low concentrations (MIC, ≦0.004–0.125 µg/ml), with dermatophytes being most susceptible (MIC, ≦0.004–0.008 µg/ml). As a 1% topical cream, it is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum and Epidermophyton floccosum.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 354.28 |
---|---|
Molecular Formula | C14H9Cl2N3S2 |
CAS No. | 187164-19-8 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 71 mg/mL (200.4 mM)r |
Water: <1 mg/mLr | |
Ethanol: 5 mg/mL (14.1 mM) | |
SMILES Code | N#C/C(N1C=CN=C1)=C2SC[C@@H](C3=CC=C(Cl)C=C3Cl)S/2 |
Synonyms | PR2699; NND502; PR 2699; NND502; PR2699; NND 502; Luzu; Lulicon |
Protocol | In Vitro | In vitro activity: Luliconazole inhibits growth of all filamentous fungi except zygomycetes at low concentrations (MIC, ≦0.004–0.125 µg/ml), with dermatophytes being most susceptible (MIC, ≦0.004–0.008 µg/ml). Luliconazole demonstrates greater potency against Trichophyton spp. |
---|---|---|
In Vivo | Luliconazole (1% cream) treatment produces a clinical effi cacy somewhat below terbinafine with 50.8% in a guinea pig model of dermatophytosis. Luliconazole (1% cream) treated guinea pigs have hairs covered with amorphous debris and a small number of conidia are detected. The improved efficacy of Luliconazole over Lanoconazole is likely due to Luliconazole being strictly an R-enantiomer while lanoconazole is a racemic mixture. | |
Animal model | Guinea pigs | |
Dosages | 0.02%-1% | |
Administration | Appliance on skin; 0.02%-1%; 7-14 days |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.8226 mL | 14.1131 mL | 28.2263 mL | 56.4525 mL |
5mM | 0.5645 mL | 2.8226 mL | 5.6453 mL | 11.2905 mL |
10mM | 0.2823 mL | 1.4113 mL | 2.8226 mL | 5.6453 mL |
20mM | 0.1411 mL | 0.7057 mL | 1.4113 mL | 2.8226 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.